Showing 1 - 2 results of 2 for search 'Jane N Winter', query time: 0.02s Refine Results
  1. 1
    Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

    Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma by Reem Karmali, Frederique St‐Pierre, Shuo Ma, Kelly D. Foster, Jason Kaplan, Xinlei Mi, Barbara Pro, Jane N. Winter, Leo I. Gordon

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

    Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL r... by Carlo Visco, Alexander Tzankov, Zijun Y. Xu-Monette, Roberto N. Miranda, Yu Chuan Tai, Yan Li, Wei-min Liu, Emanuele S. G. d'Amore, Yong Li, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Huan-You Wang, Cherie H. Dunphy, Eric D. His, X. Frank Zhao, William WL. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Weiyun Ai, Stacey O'Neill, Maurilio Ponzoni, Andres JM. Ferreri, Brad S. Kahl, Jane N. Winter, Ronald S. Go, Stephan Dirnhofer, Miguel A. Piris, Michael B. Møller, Lin Wu, L. Jeffrey Medeiros, Ken H. Young

    Published 2013-02-01
    Get full text
    Article

Search Tools: